Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization

Ya-Hsin Kung, Kai-Ling Peng, Lu-Yang Shih, Tsung-Tien Wu

Open source

DOI: 10.1097/md.0000000000048925
Published: 2026-05-22
Container: Medicine
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000048925,
  title = {Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization},
  author = {Ya-Hsin Kung and Kai-Ling Peng and Lu-Yang Shih and Tsung-Tien Wu},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000048925},
  url = {https://doi.org/10.1097/md.0000000000048925}
}

RIS

TY  - JOUR
TI  - Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization
AU  - Ya-Hsin Kung
AU  - Kai-Ling Peng
AU  - Lu-Yang Shih
AU  - Tsung-Tien Wu
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000048925
UR  - https://doi.org/10.1097/md.0000000000048925
ER  -

APA

Kung, Y., Peng, K., Shih, L., & Wu, T. (2026). Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization. Medicine. https://doi.org/10.1097/md.0000000000048925

Source records

crossref · retrieved 2026-09-26T05:13:42.951Z